0001209191-24-004948.txt : 20240319 0001209191-24-004948.hdr.sgml : 20240319 20240319174644 ACCESSION NUMBER: 0001209191-24-004948 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spaventa Andrew CENTRAL INDEX KEY: 0001859701 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40443 FILM NUMBER: 24765283 MAIL ADDRESS: STREET 1: 10931 N. TORREY PINES ROAD, SUITE 100 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Singular Genomics Systems, Inc. CENTRAL INDEX KEY: 0001850906 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 812948451 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-7830 MAIL ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-03-15 0 0001850906 Singular Genomics Systems, Inc. OMIC 0001859701 Spaventa Andrew 3010 SCIENCE PARK ROAD SAN DIEGO CA 92121 1 1 0 0 Chief Executive Officer 0 Common Stock 2024-03-15 4 M 0 14583 A 24349 D Common Stock 2024-03-15 4 G 0 14583 0.00 D 9766 D Common Stock 2024-03-15 4 G 0 14583 0.00 A 4090372 I By The Andrew K. Spaventa Living Trust dated April 9, 2014 Common Stock 2569 I By Axon Holdings, LLC Restricted Stock Units 2024-03-15 4 M 0 14583 D Common Stock 14583 175000 D Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Immediately upon vesting of the Reporting Person's RSUs, the Reporting Person transferred his shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014. Due to an administrative error, 2,569 shares were previously reported as distributed on March 24, 2022, but were not distributed. The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in 16 equal quarterly installments measured from March 15, 2023. /s/ Dalen Meeter, Attorney-in-Fact 2024-03-19